My name is Frank Vandenbussche, Belgian nationality, professor of obstetrics and fetal medicine, Department of Obstetrics and Gynaecology, theme Reconstructive and regenerative medicine.
When you were a kid what did you want to be when you grew up? Can you tell us something about your child years.
I always liked to read and write, but also to perform. Swimming and playing soccer made me happy. I thought about studying law and then be a reporter of war or work for amnesty international, something like that. It came differently, yes, but still reading and writing, searching for truth, trying to help people, performing for an international audience..
What was your previous academic training, where did you study and why that study?
Military school, then sports education, then medicine and tropical medicine in Belgium, fell in love with obstetrics and ultrasound, specialty training in Germany.
The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you?
Molecules for diagnosis, molecules for therapy. One formula that the whole world will start to use. A fantastic motto. But I am a (simple) clinician, counseling and operating on single patients, working on quality improvement in this hospital and in the smaller and larger region, performing clinical studies, together with engineers planing and filing on operational instruments and techniques, researching on the similarities and differences between fetal and adult physiology.
Who is your great example as scientists? And please give a motivation why.
I read “The double helix” by James Watson when I was 20 years old and found it very stimulating that a 24 year old biology student, by combining existing knowledge from 3 different fields, could uncover the great secret of reproduction. By solving the puzzle (because it was known which molecules, in what ratio, and with which dimensions) he and Crick could see that their structure fulfilled all the requirements that the carrier of the hereditary information had to meet. What a moment! And then the letter to Nature..
Which research discovery that you have made has made you most proud?
In monochorionic twins, two fetuses share one circulation. A common complication of this is that one fetus becomes hypervolemic, the other one hypovolemic (feto-fetal transfusion syndrome). I started a minimal invasive therapy in the NL where we separated the circulations with laser coagulation of placental vessels, saving many lives. One day, a gynecologist in Utrecht called me and said that 12 weeks after the therapy, both babies were born normovolemic, but one was anemic and the other one polycytemic. We searched our database and our placental library and discovered the cause of this “twin anemia polycytemia syndrome”. I called my colleagues of the fetal centers in Belgium and Spain and found confirmation there. It is a well known syndrome now, we know how to prevent and treat it.
Given unlimited finance what experiment would you perform?
I would start with three teams to substantially improve the minimally invasive prenatal therapy of spina bifida (anatomical border detection, instrument development for surgical separation, regenerative medicine for reconstruction). I would be ready in less than 5 years, preventing many handicaps and giving pregnant women an alternative to abortion.
What does your working area (desk, office) look like and what does it say about you (or your research)?
My desk is sometimes messy and sometimes clean. My time management follows the flow.
Nominate a colleague to be in the spotlight and what would you like to ask him or her?
Joost Wagener is an executive manager in the Radboudumc and I would like to ask him about his military career and his war experiences in the past and how he came to change his career and started working in hospitals.
What type of person are you, quick insights:a) Mac or PC? : Both
b) Theater or cinema? : Cinema
c) Dine out or dine in? : Both
d) Ferrari or Fiat? : VW Buli
e) Shopaholic or chocoholic? : None
f) Culture or Nature : Nature
Related news items
Radium 223-mediated zonal cytotoxicity of prostate cancer in bone21 January 2019
In preclinical prostate carcinoma in the bone, Rad-223 eradicated effectively micro-tumors but macro-tumors persisted and expanded. The data point to application of Rad-223 in secondary prevention of early bone-metastatic disease and regimens co-targeting the tumor core.read more
COPAL reveals remodeling of mitochondrial protein complexes in Barth syndrome21 January 2019
Martijn Huijnen, theme Mitochondrial diseases, and colleagues developed COmplexome Profiling ALignment (COPAL) to systematically asses the effect of Barth syndome on mitochondrial protein complexes. They published their findings in Bioinformatics.read more
Two papers on molecular mechanisms of GFI1B in inherited bleeding syndromes in Haematologica21 January 2019
Rinske van Oorschot from the Van der Reijden group, theme Cancer development and immune defense, has published two papers on the transcription factor GFI1B in Haematologica.read more
Blog: Species Differences The Elephant in the Room17 January 2019
Read the blog of Merel Ritskes-Hoitinga in the New England anti-vivisection society (neavs) based on a paper published in the Journal of Translational Medicine.read more
LEO Foundation grant for Ellen van den Bogaard and Patrick Zeeuwen17 January 2019
LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide that improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms.read more